Strikingly, PROX1 expression was 1.4-fold higher in HCC than in CCA24, and survival in patients with HCC with high PROX1 expression is better compared to CCA (Fig. 7a and Extended Data Fig. 9a). This evidence concerns the gene PROX1 and cholangiocarcinoma.